Podcast
CDMO Consolidation “Inevitable” Without Business Model Shift, Warns Cell Therapy CEO
“CDMOs and Biotechs will both die,” warns NKILT Therapeutics CEO as he talks candidly about the funding crisis stalling cell therapy development, predicting widespread consolidation across biotechs and CDMOs unless the industry shifts toward risk-sharing partnership models that align manufacturing
16 December 2020